Skip to main content
. 2024 Jun 5;13(7):1130–1143. doi: 10.1002/psp4.13145

TABLE 1.

Baseline characteristics of the 538 patients included depending on their vital status at D28. The median and interquartile range is given for continuous covariates, and the percentage is given for categorical covariates.

Alive, N = 425 Dead, N = 94 Censored, N = 19 Overall population, N = 538 Missing
Continuous covariates – Median [Q1;Q3]
Age (years) 64 [54;70] 71 [64;78] 72 [57;74] 65 [56;72] 0
Weight (kg) 85 [74;97] 80 [70;91] 80 [68;90] 84 [73;96] 1
Height (cm) 170 [165;176] 170 [164;174] 168 [160;177] 170 [164;176] 6
BMI (kg/m2) 29 [26;33] 28 [25;31] 28 [27;33] 29 [26;33] 6
Charlson index 2 [1;2] 3 [1;4] 1 [1;2] 2 [1;3] 0
Time between first symptoms and ICU admission (days) 9 [7;11] 7 [4;9] 10 [3;11] 9 [6;11] 10
Length of hospital stay (days) 19 [11;41] 14 [8;21] 10 [8;16] 18 [11;34] 5
Length of ICU stay (days) 8 [4;21] 12 [7;19] 7 [3;10] 9 [5;20] 1
SOFA score 2 [1;4] 4 [2;7] 1 [0;4.5] 3 [1;5] 0
SAPSII score 30 [22;37] 38 [30;47] 30 [22;44] 31 [24;40] 0
Glasgow coma scale 15 [15;15] 15 [15;15] 15 [14.5;15] 15 [15;15] 1
Categorical covariates – n (%)
Male gender 298 (70) 75 (80) 19 (53) 383 (71) 0
Mechanical ventilation before 3rd day in ICU 122 (29) 45 (48) 6 (32) 173 (32) 0
Mac Cabe index 209
Stage 1 a 1 (0.4) 3 (5.3) 0 (0) 4 (1)
Stage 2 b 20 (7.6) 10 (18) 2 (25) 32 (10)
Stage 3 c 243 (92) 44 (77) 6 (75) 293 (89)
Preexisting immunological disease 32 (7.5) 17 (18) 0 (0) 49 (9) 0
Treatment by ARA II d 59 (14) 15 (16) 2 (11) 76 (14) 0
Origin 0
Exterior 260 (61) 60 (64) 12 (63) 332 (62)
COVID unit 75 (18) 8 (9) 1 (5) 84 (16)
Hospital e 76 (18) 24 (26) 6 (32) 106 (20)
Other 14 (3) 2 (2) 0 (0) 16 (3)
ARDS f 165 (41) 69 (78) 8 (42) 242 (47) 26
Nosocomial infections 117 (32) 45 (57) 5 (26) 167 (36) 79
Vital status at day 90
Alive 353 (93) 0 (0) 0 (0) 353 (74) 64
Dead 27 (7) 94 (100) 0 (0) 121 (26)
COVID wave g 0
1 51 (12) 16 (17) 0 (0) 67 (12)
2 142 (33) 36 (38) 8 (42) 186 (35)
3 142 (33) 21 (22) 9 (47) 172 (32)
4 90 (21) 21 (22) 2 (11) 113 (21)
a

Disease deadly within a year.

b

Life threatening disease at 5 years.

c

No threatening disease.

d

Angiotensin II Receptor Antagonist.

e

Except COVID unit.

f

Acute Respiratory Distress Syndrome.

g

COVID wave: 1: from March 2020 to July 5th 2020. 2: from July 6th 2020 to January 3rd 2021. 3: from January 4th 2021 to July 4th 2021. 4: after July 5th 2021.